menu
    • menu

    Company profile for GALDERMA LABS LP

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Since our inception in 1981 as a joint venture between L'Oréal and Nestlé, Galderma's sole focus is dermatology. Approximately 130 million Americans suffer from skin diseases. Skin is the largest and the most visible organ of the human body. Skin conditions can significantly impact an individual's physical health as well as his or her psychosocial well-being. There is also increasing evidence of a much stronger relations...
    Since our inception in 1981 as a joint venture between L'Oréal and Nestlé, Galderma's sole focus is dermatology. Approximately 130 million Americans suffer from skin diseases. Skin is the largest and the most visible organ of the human body. Skin conditions can significantly impact an individual's physical health as well as his or her psychosocial well-being. There is also increasing evidence of a much stronger relationship between skin and internal disorders. Therefore, at Galderma, we recognize that dermatology holds a distinctive position in improving human health. Over our 30 year history, our commitment to dermatology has been demonstrated by our ongoing collaboration with dermatologists, pediatricians and healthcare professionals, dermatological, medical institutions and non-profit research foundations in the United States and worldwide. Galderma has been recognized as the #1 dermatological company by dermatologists in the United States for the last seven consecutive years for the quality of our products, R&D, marketing and medical programs and sales force.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GALDERMA LABS LPUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    14501 N. Freeway Ft. Worth, TX 76177
    Telephone
    Telephone
    817.961.5014
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.galderma.com/us/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galderma`s Biologic Nemluvio Receives Approval in US
    Galderma`s Biologic Nemluvio Receives Approval in US

    13 Dec 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761391

    FDA
    13 Dec 2024
    Share Share
    Galderma Acne treatment receives approval from Europe
    Galderma Acne treatment receives approval from Europe

    20 Dec 2019

    // PHARMAFILE

    http://www.pharmafile.com/news/536089/galderma-acne-treatment-receives-approval-europe

    PHARMAFILE
    20 Dec 2019
    Share Share
    Galderma receives +ve outcome through EU Decentralised Procedure for AKLIEF
    Galderma receives +ve outcome through EU Decentralised Procedure for AKLIEF

    20 Dec 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191220005031/en

    BUSINESSWIRE
    20 Dec 2019
    Share Share
    Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation
    Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation

    24 Oct 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/galderma-demonstrates-robust-aesthetic-innovation-pipeline-with-initiation-of-seven-new-clinical-studies-300944430.html

    PR NEWSWIRE
    24 Oct 2019
    Share Share
    Galderma Announces Positive Phase 2 Results forBotulinum Toxin a
    Galderma Announces Positive Phase 2 Results forBotulinum Toxin a

    09 Oct 2019

    // PRNEWS WIRE

    https://www.prnewswire.com/news-releases/galderma-announces-positive-phase-2-results-for-its-proprietary-liquid-formulation-of-an-investigational-botulinum-toxin-and-approval-of-new-state-of-the-art-manufacturing-facility-300934292.html

    PRNEWS WIRE
    09 Oct 2019
    Share Share
    Galderma Advances Phase 3 Clinical Study with Nemolizumab
    Galderma Advances Phase 3 Clinical Study with Nemolizumab

    09 Oct 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191010005291/en

    BUSINESSWIRE
    09 Oct 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search